Hydroxyzine (brand names Vistaril, Atarax) is a first-generation antihistamine of the diphenylmethane and piperazine class. It was initially synthesized in 1956 and thereafter marketed in the U.S. by the pharmaceutical juggernaut, Pfizer. Although a relatively ancient medication by today’s standards, hydroxyzine is still commonly prescribed: as a preoperative anesthetic, analgesic, and anxiolytic adjunct; as an antiallergic agent for atopic dermatitis, chronic hives, and pruritus; and on occasion, as a neuropsychiatric intervention for generalized anxiety disorder, and alcohol withdrawal.
Research of hydroxyzine (Atarax, Vistaril) for the treatment of anxiety suggests that it is equally effective and tolerable to FDA approved anxiolytics such as Buspar and benzodiazepines. In fact, some speculate that it may be a safer option than benzodiazepines due to its low propensity for abuse, dependence, and toxicity. These findings have lead many individuals with severe anxiety disorders to actively pursue hydroxyzine as a pharmacological intervention.
Address: 5636 Lemon Ave.
Dallas TX 75209
Phone: +1 214 5203694